封面
市场调查报告书
商品编码
1708612

生物模拟市场:按产品/服务、应用、分销管道和地区划分

Biosimulation Market, By Product and Services, By Application, By Distribution Channel, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 159 Pages | 商品交期: 2-3个工作天内

价格
简介目录

预计到 2025 年全球生物模拟市场规模将达到 27.77 亿美元,到 2032 年将达到 86.899 亿美元,2025 年至 2032 年的年复合成长率(CAGR)为 17.7%。

报告范围 报告详细信息
基准年 2024 2025年的市场规模 27.77亿美元
效能数据 2020-2024 预测期 2025-2032
预测期间:2025年至2032年的复合年增长率 17.70% 2032年价值预测 86.899亿美元
数字。 2025年生物模拟市场占有率(按地区)
生物模拟市场-IMG1

生物模拟是一种计算模型,使用电脑模拟来模拟人体内的生物过程、系统和途径。它帮助我们了解人体在分子和细胞层面上如何运作,以及某些医疗干预措施(如药物和医疗设备)如何发挥作用。透过从分子到组织层级等多个尺度模拟疾病机制、进展和与治疗性介入的相互作用,生物模拟可以帮助减少药物开发过程中对大量实验室和临床测试的需求。这降低了成本,提高了效率并加快了药物研发。

市场动态

全球生物模拟市场的成长受到多种因素的推动,例如製药和生物技术行业研发支出的增加、对降低药物开发成本和开发时间的日益重视、个性化医疗的采用率的提高、慢性病患病率的增加以及生物模拟领域技术的快速进步。然而,由于缺乏处理复杂生物模拟工具和模型所需的合格IT基础设施和熟练的专业人员,市场成长可能会受到抑制。该市场的关键机会来自于生物模拟应用领域的不断扩大,例如疫苗开发、饮食和毒性分析、组织工程和个人化医疗,以及产业界和学术界之间为进一步推进该技术而进行的持续合作。

近年来,全球生物模拟市场经历了重大技术进步,带来了新的机会和应用。生物模拟是利用电脑建模和模拟来研究和预测生物过程。这使得研究人员能够模拟细胞、组织和整个生物体等生物系统,以便更好地了解疾病并测试新的治疗方法。

研究的主要特点

  • 本报告对全球生物模拟市场进行了详细分析,并以 2024 年为基准年,给出了预测期(2025-2032 年)的市场规模和年复合成长率(CAGR%)。
  • 它还强调了各个领域的潜在商机,并说明了该市场的有吸引力的投资提案矩阵。
  • 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的重要见解。
  • 全球生物模拟市场的主要企业是根据公司亮点、产品系列、关键亮点、财务绩效和策略等参数进行的分析。
  • 本报告的见解将使负责人和企业经营团队能够就未来的产品发布、新兴趋势、市场扩张和行销策略做出明智的决策。
  • 全球生物模拟市场报告针对该行业的各个相关人员,包括投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
  • 相关人员可以透过全球生物模拟市场分析中使用的各种策略矩阵更轻鬆地做出决策。

目录

第一章 调查目的与前提条件

  • 研究目标
  • 先决条件
  • 简称

第二章 市场展望

  • 报告描述
    • 市场定义和范围
  • 执行摘要
  • 一致的机会图(COM)

第三章市场动态、法规与趋势分析

  • 市场动态
    • 驱动程式
    • 限制因素
    • 机会
  • 影响分析
  • 监管情景
  • 产品发布/核准
  • PEST分析
  • 波特分析
  • 併购场景

第四章 全球生物模拟市场-冠状病毒(COVID-19)大流行的影响

  • COVID-19流行病学
  • 供需侧分析
  • 经济影响

5. 全球生物模拟市场(依产品和服务划分),2020 年至 2032 年

  • 介绍
  • 软体
  • 服务

6. 全球生物模拟市场(依应用划分),2020 年至 2032 年

  • 介绍
  • 药物研发
  • 药物开发

7. 2020-2032 年全球生物模拟市场(按分销管道)

  • 介绍
  • 医院药房
  • 零售药局
  • 网路药局

8. 2020-2032 年全球生物模拟市场(按地区)

  • 介绍
  • 北美洲
  • 拉丁美洲
  • 欧洲
  • 亚太地区
  • 中东
  • 非洲

第九章 竞争态势

  • Certara, LP
  • Simulations Plus, Inc.
  • Dassault Systemes(Accelrys)
  • Genedata AG
  • LeadScope, Inc.
  • Compugen Inc.
  • Schrodinger, LLC
  • In Silico Biosciences, Inc.
  • Advanced Chemistry Development, Inc.
  • Chemical Computing Group ULC
  • Physiomics PLC
  • Pharmaceutical Product Development, LLC(Evidera)

第 10 章 章节

  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI2016

Global Biosimulation Market is estimated to be valued at USD 2,777. Mn in 2025 and is expected to reach USD 8,689.9 Mn by 2032, growing at a compound annual growth rate (CAGR) of 17.7% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 2,777. Mn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 17.70% 2032 Value Projection: USD 8,689.9 Mn
Figure. Biosimulation Market Share (%), By Region 2025
Biosimulation Market - IMG1

Biosimulation is a computational model that is used to simulate biological processes, systems, and pathways of the human body using computer simulations. It aids in understanding how the body functions at molecular and cellular levels and how certain medical interventions such as drugs or medical devices are likely to behave in it. By simulating disease mechanisms, progressions and their interaction with therapeutic interventions at various scales from molecule to tissue, biosimulation aids in reducing the need for extensive laboratory and clinical testing during drug development processes. This leads to lower costs, greater efficiency, and faster drug discovery.

Market Dynamics:

Global biosimulation market growth is driven by factors such as rising R&D expenditure in pharmaceutical and biotechnology industries, growing emphasis on reducing drug development costs and time, increasing adoption of personalized medicine, growing prevalence of chronic diseases, and rapid technological advancements in field of biosimulation. However, the market growth can be restrained due to lack of competent IT infrastructure and skilled professionals required for handling complex biosimulation tools and models. Major opportunity for this market lies in growing application areas of biosimulation including vaccine development, dietary and toxicity analysis, tissue engineering, personalized medicine, and others and ongoing collaborations between industries and academic institutions for further advancement of technology.

Global biosimulation market has witnessed tremendous technological progress in the recent years, and this offers new opportunities and applications. Biosimulation uses computer modeling and simulation to study and predict biological processes. It allows researchers to simulate biological systems like cells, tissues and entire organisms to better understand disease and test new drug treatments.

Key features of the study:

  • This report provides in-depth analysis of the global biosimulation market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global biosimulation market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Certara, L.P., Simulations Plus, Inc., Dassault Systemes (Accelrys), Genedata AG, LeadScope, Inc., Compugen Inc., Schrodinger, LLC, In Silico Biosciences, Inc., Advanced Chemistry Development, Inc., Chemical Computing Group ULC, Physiomics PLC, and Pharmaceutical Product Development, LLC (Evidera)
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global biosimulation market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global biosimulation market

Biosimulation Market Detailed Segmentation:

  • By Product and Services
    • Software
    • Services
  • By Application
    • Drug Discovery
    • Drug Development
  • By Distribution Channel
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • By Region
    • North America
    • Latin America
    • Europe
    • Asia Pacific
    • Middle East
    • Africa
  • Company Profiles
    • Certara, L.P.
    • Simulations Plus, Inc.
    • Dassault Systemes (Accelrys)
    • Genedata AG
    • LeadScope, Inc.
    • Compugen Inc.
    • Schrodinger, LLC
    • In Silico Biosciences, Inc.
    • Advanced Chemistry Development, Inc.
    • Chemical Computing Group ULC
    • Physiomics PLC
    • Pharmaceutical Product Development, LLC (Evidera)

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Biosimulation Market Snippet, By Product and Services
    • Global Biosimulation Market Snippet, By Application
    • Global Biosimulation Market Snippet, By Distribution Channel
    • Global Biosimulation Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Biosimulation Market- Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Biosimulation Market, By Product and Services, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Software
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
  • Services
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)

6. Global Biosimulation Market, By Application, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Drug Discovery
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
  • Drug Development
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)

7. Global Biosimulation Market, By Distribution Channel, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)

8. Global Biosimulation Market, By Region, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Country, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Country 2021 -2032
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product and Services, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product and Services, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product and Services, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product and Services, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product and Services, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product and Services, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032, (US$ Mn)
      • South Africa
      • North Africa
      • Central Africa

9. Competitive Landscape

  • Certara, L.P.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Simulations Plus, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Dassault Systemes (Accelrys)
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Genedata AG
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • LeadScope, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Compugen Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Schrodinger, LLC
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • In Silico Biosciences, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Advanced Chemistry Development, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Chemical Computing Group ULC
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Physiomics PLC
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Pharmaceutical Product Development, LLC (Evidera)
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Analyst Views

10. Section

  • Research Methodology
  • About us